HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation.

AbstractBACKGROUND:
Acute pericarditis is a known complication of ablation procedures for atrial fibrillation (AF).
OBJECTIVES:
This study aimed to evaluate the benefits of colchicine monotherapy in terms of reducing the risk of pericarditis and related hospitalization rate in AF patients undergoing catheter ablation.
METHODS:
Consecutive AF patients undergoing first catheter ablation were classified into 3 groups based on their colchicine use: Group 1: no colchicine; group 2: colchicine from 7 days before to 1 month after ablation; and group 3: colchicine from the day of the procedure to 1 month after. Standard institutional protocol was used to follow all patients for 1 year.
RESULTS:
A total of 1,075 patients were classified into groups 1 (n = 607), 2 (n = 213), and 3 (n = 255). Symptoms of acute pericarditis were reported in 129 patients (12%): group 1: n = 106 (17.5%); group 2: n = 4 (1.9%); and group 3: n = 19 (7.5%); P < 0.001. Rate of mild-moderate as well as severe pericarditis were significantly lower in group 2. In the multivariable regression analysis, pre- and post-ablation colchicine use was seen to be associated with significantly lower risk of acute pericarditis and related hospitalization compared with the other 2 groups. In addition, at 1-year follow-up, arrhythmia-free survival rate was significantly higher in paroxysmal AF patients receiving colchicine compared with the no-colchicine population.
CONCLUSIONS:
Colchicine therapy starting 7 days before to 1 month after the ablation procedure was associated with significantly lower risk of acute pericarditis and related hospitalization. In addition, paroxysmal AF patients receiving colchicine had a higher arrhythmia-free survival rate compared with those not receiving colchicine.
AuthorsSanghamitra Mohanty, Prasant Mohanty, Danielle Kessler, Carola Gianni, Karim K Baho, Trevor Morris, Tuna Yildiz, Angel Quintero Mayedo, Bryan MacDonald, Domenico G Della Rocca, Amin Al-Ahmad, Mohamed Bassiouny, G Joseph Gallinghouse, Rodney Horton, John D Burkhardt, Luigi di Biase, Andrea Natale
JournalJACC. Clinical electrophysiology (JACC Clin Electrophysiol) Vol. 9 Issue 7 Pt 2 Pg. 1051-1059 (07 2023) ISSN: 2405-5018 [Electronic] United States
PMID37086226 (Publication Type: Journal Article)
CopyrightCopyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Colchicine
Topics
  • Humans
  • Atrial Fibrillation (drug therapy, surgery, diagnosis)
  • Treatment Outcome
  • Colchicine (therapeutic use)
  • Catheter Ablation (adverse effects, methods)
  • Pericarditis (epidemiology, etiology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: